021-51111890
购物车（）
sales@molnova.cn
Azalanstat
CAS No. 143393-27-5
Azalanstat ( —— )
产品货号. M34054 CAS No. 143393-27-5
Azalanstat (RS 21607) is an orally available selective mammalian lanosterol 14-alpha-demethylase inhibitor with hypocholesterolemic activity that inhibits cholesterol synthesis in HepG2 cells, human fibroblasts, hamster hepatocytes, and hamster livers through inhibition of the cytochrome P450 enzyme, lanosterol 14 alpha demethylase.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥4674 | 有现货 |
|
| 10MG | ￥6774 | 有现货 |
|
| 25MG | ￥9858 | 有现货 |
|
| 50MG | ￥12834 | 有现货 |
|
| 100MG | ￥15750 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Azalanstat
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Azalanstat (RS 21607) is an orally available selective mammalian lanosterol 14-alpha-demethylase inhibitor with hypocholesterolemic activity that inhibits cholesterol synthesis in HepG2 cells, human fibroblasts, hamster hepatocytes, and hamster livers through inhibition of the cytochrome P450 enzyme, lanosterol 14 alpha demethylase.
-
产品描述Azalanstat (RS 21607) is an orally available selective mammalian lanosterol 14-alpha-demethylase inhibitor with hypocholesterolemic activity that inhibits cholesterol synthesis in HepG2 cells, human fibroblasts, hamster hepatocytes, and hamster livers through inhibition of the cytochrome P450 enzyme, lanosterol 14 alpha demethylase.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Metabolic Enzyme/Protease
-
靶点P450
-
受体P450
-
研究领域——
-
适应症——
化学信息
-
CAS Number143393-27-5
-
分子量429.96
-
分子式C22H24ClN3O2S
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESC([C@]1(CCC2=CC=C(Cl)C=C2)O[C@H](CSC3=CC=C(N)C=C3)CO1)N4C=CN=C4
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
7-Hydroxyflavone
7-Hydroxyflavone 是一种有效的 CYP1A1 抑制剂，Ki 值为 0.015 μM，对 CYP1A1 的选择性比 CYP1A2 高 6 倍，并具有抗炎活性。
-
Tiliroside
替利罗苷具有抗氧化和抗炎活性，可以抑制神经退行性疾病中的神经炎症。
-
FLAVOKAVAIN A(P)
FLAVOKAVAIN A(P) 是一种从卡瓦提取物中提取的新型查尔酮，通过参与 Bax 蛋白依赖性和线粒体依赖性细胞凋亡途径诱导膀胱癌细胞凋亡，并抑制小鼠肿瘤生长。
